(TSX:CGY), OTTAWA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) — Calian(R) Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, will hold a conference call at 8:30 a.m. Eastern Time on Thursday, February 13, 2025, to discuss results for the three-month period ended December 31, 2024. The results […]
(NYSE:TOL), PARKER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the highly anticipated opening of Toll Brothers at Cherry Creek Trail, a luxury community of ranch-style homes in Douglas County, Colorado. The Toll Brothers Sales Center is now open at 6289 Moxie Circle
DICK'S and Texas Athletics Ink Exclusive Multi-Year Sponsorship Featuring Student-Athlete NIL Opportunities Today, The University of Texas at Austin Athletics and DICK'S Sporting Goods announced an exclusive multi-year brand sponsorship that names DICK'S as the “Official Sporting Goods Retailer of the Texas Longhorns.” https://mma.prnewswire.com/media/2609822/Dicks_Press_Release_Creative_Logo.jpg In addition to co-branding with the iconic Texas Longhorns logo in
Global logistics expansion and alternative solutions help medical OEMs maintain momentum. ROMEOVILLE, IL / ACCESS Newswire / January 30, 2025 / Formerra, a leader in performance materials distribution, will spotlight its extended abilities to address the evolving challenges faced by medical device manufacturers at the upcoming MD&M West in Anaheim, California. The company’s latest initiatives
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XBiotech Inc.("XBiotech" or the "Company") (NASDAQ:XBIT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns Micron and certain of its officers and/or directors have engaged in
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ:NTLA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, ext.â?¯7980. The investigation concerns whether Intellia and certain of its officers and/or directors have engaged
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ:ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Atara and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TELUS International (Cda) Inc. ("Telus" or the "Company") (NASDAQ:TIXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Telus and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. ("Pacira" or the "Company") (NASDAQ:PCRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited("Capri" or the "Company") (NYSE:CPRI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capri and certain of its officers and/or directors